tradingkey.logo

tradingkey.logo
怜玢


STAAR Surgical Co

STAA
りォッチリストに远加
32.070USD
+0.060+0.19%
終倀 05/15, 16:00ET15分遅れの株䟡
1.58B時䟡総額
損倱額盎近12ヶ月PER


詳现情報 STAAR Surgical Co 䌁業名

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Coの䌁業情報


䌁業コヌドSTAA
䌚瀟名STAAR Surgical Co
䞊堎日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)
埓業員数1157
蚌刞皮類Ordinary Share
決算期末Feb 24
本瀟所圚地1911 Walker Ave
郜垂MONROVIA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号91016
電話番号16263037902
りェブサむトhttps://www.staar.com/
䌁業コヌドSTAA
䞊堎日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)

STAAR Surgical Coの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Others
93.84M
39.19%
China
77.78M
32.48%
Japan
45.27M
18.90%
U. S.
22.56M
9.42%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
他の
36.94%
株䞻統蚈
株䞻統蚈
比率
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
他の
36.94%
皮類
株䞻統蚈
比率
Hedge Fund
53.68%
Investment Advisor
31.49%
Investment Advisor/Hedge Fund
21.11%
Research Firm
6.23%
Pension Fund
1.00%
Individual Investor
0.66%
Bank and Trust
0.36%
Venture Capital
0.06%
Insurance Company
0.02%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
543
58.06M
116.62%
-10.58M
2025Q4
536
52.38M
105.30%
-16.01M
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Broadwood Capital, Inc.
16.12M
32.56%
+670.21K
+4.34%
Mar 13, 2026
BlackRock Institutional Trust Company, N.A.
6.69M
13.51%
+107.78K
+1.64%
Dec 31, 2025
Yunqi Capital Limited
3.26M
6.58%
+750.00K
+29.91%
Jan 14, 2026
Magnetar Capital Partners LP
2.47M
4.99%
+1.27M
+105.28%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.97M
3.98%
+1.11M
+128.32%
Dec 31, 2025
State Street Investment Management (US)
1.94M
3.92%
+29.50K
+1.54%
Dec 31, 2025
Balyasny Asset Management LP
1.54M
3.11%
-272.35K
-15.02%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
詳现を芋る
AltShares Merger Arbitrage ETF
比率2.71%
ProShares Merger ETF
比率2.53%
State Street SPDR S&P Health Care Equipment ETF
比率1.67%
NYLI Merger Arbitrage ETF
比率0.87%
Invesco S&P SmallCap Health Care ETF
比率0.79%
Royce Quant Small-Cap Quality Value ETF
比率0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
比率0.13%
iShares S&P Small-Cap 600 Growth ETF
比率0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
比率0.1%
iShares ESG Select Screened S&P Small-Cap ETF
比率0.1%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™